title: Effect of hepatic portal infusion of pyruvate on pancreatic hormone response during exercise.
abstract: The purpose of the present investigation was to evaluate the effects of a small infusion of pyruvate into the hepatic portal vein on the pancreatic hormone response during exercise (30-min treadmill run; 26 m/min, 0% grade) in adrenodemedullated rats. Resting and exercising rats were infused with either pyruvate (5% solution; 0.016 ml/min) into the portal vein, pyruvate into the jugular vein, or saline into the portal vein. Peripheral and portal blood glucose concentrations were decreased (P < 0.01) similarly in all groups after the exercise period. Peripheral insulin, glucagon, and norepinephrine levels, either at rest or after exercise, were not significantly affected by the infusions. The response of portal pancreatic hormone concentrations to exercise was, however, reduced by the pyruvate infused into the portal and jugular veins for insulin and into the portal vein only for glucagon. The normal increase in peripheral glucagon-insulin molar ratio during exercise was shut down by the infusion of pyruvate into the portal vein but not by the infusion of pyruvate into the jugular vein or by the infusion of saline. These results indicate that a small blood infusion of pyruvate, even in the presence of a decreasing blood glucose level, can attenuate substantially the pancreatic hormone response during exercise in adrenodemedullated rats.
authors.affiliation: Département d'Education Physique, Université de Montréal, Quebec, Canada.
authors.forename: S
authors.initials: S
authors.lastname: Cardin
authors.forename: R
authors.initials: R
authors.lastname: Hélie
authors.forename: R
authors.initials: R
authors.lastname: Bergeron
authors.forename: B
authors.initials: B
authors.lastname: Comte
authors.forename: G
authors.initials: G
authors.lastname: van de Werve
authors.forename: J M
authors.initials: JM
authors.lastname: Lavoie
mesh_terms: D000818:Animals; D001786:Blood Glucose / Q000378:metabolism; D005934:Glucagon / Q000097:blood / Q000378:metabolism*; D007261:Infusions, Intra-Arterial; D007328:Insulin / Q000097:blood / Q000378:metabolism*; D000078790:Insulin Secretion; D007515:Islets of Langerhans / Q000187:drug effects / Q000378:metabolism*; D007601:Jugular Veins; D008297:Male; D009638:Norepinephrine / Q000097:blood / Q000378:metabolism; D010179:Pancreas / Q000187:drug effects / Q000378:metabolism*; D011169:Portal Vein; D011773:Pyruvates / Q000008:administration & dosage / Q000494:pharmacology*; D019289:Pyruvic Acid; D051381:Rats; D017207:Rats, Sprague-Dawley; D012146:Rest
chemical_list: D001786:Blood Glucose; D007328:Insulin; D011773:Pyruvates; D019289:Pyruvic Acid; D005934:Glucagon; D009638:Norepinephrine